Several stakeholders are involved in the pharmaceutical supply chain (PSC), including those who provide raw materials, make and sell drugs, and oversee the industry, hospitals, pharmacies, and patients. An efficient traceability system is necessary to ascertain the present and all prior ownership of products because of the intricate nature of product and transaction flows in PSC. Furthermore, regulatory supervision and product safety can be significantly improved by digitizing the track and trace procedure. A permanent, trustworthy, responsible, and transparent system in the PSC can be achieved using blockchain-based medication tracing, which provides a distributed shared data platform. A hybrid blockchain network (HBN) based on secure pharmaceutical supply chain architecture (SPSCA) has been proposed for this research. The suggested system relies on smart contracts to record significant events and track how all the parties engaged in the supply chain perform their respective tasks. In this way, everyone concerned can remain informed of developments and protect the supply against manipulations of supply records and counterfeit pharmaceuticals. All parties involved benefit from a secure, immutable record of transactions due to the smart contract, which additionally guarantees the provenance of data and deals with mediators. Detailed methods and the system architecture that enable the solution's functioning are laid out here. We perform testing and validation to assess the system's efficacy in improving pharmaceutical supply chain traceability and provide cost and security evaluations.
Read full abstract